Skip to Content

Nuveen International Dividend Growth A NUIAX

Medalist Rating as of | See Nuveen Investment Hub
  • NAV / 1-Day Return 28.49  /  −0.28 %
  • Total Assets 5.2 Mil
  • Adj. Expense Ratio
    1.150%
  • Expense Ratio 1.150%
  • Distribution Fee Level Below Average
  • Share Class Type Front Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 3,000
  • Status Open
  • TTM Yield 2.34%
  • Turnover 20%

USD | NAV as of Apr 24, 2024 | 1-Day Return as of Apr 24, 2024, 10:18 PM GMT+0

Morningstar’s Analysis NUIAX

Will NUIAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Nuveen International Dividend Growth A's Average Process Pillar and People Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings NUIAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 42.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

BAE Systems PLC

4.87 260,795
Industrials

Novo Nordisk A/S Class B

4.83 258,343
Healthcare

ITOCHU Corp

4.73 253,462
Industrials

Linde PLC

4.34 232,160
Basic Materials

Taiwan Semiconductor Manufacturing Co Ltd ADR

4.29 229,788
Technology

SAP SE

4.28 228,989
Technology

Lvmh Moet Hennessy Louis Vuitton SE

3.90 208,753
Consumer Cyclical

Sanofi SA

3.85 205,854
Healthcare

Hikma Pharmaceuticals PLC

3.75 200,688
Healthcare

Macquarie Group Ltd

3.55 189,913
Financial Services